Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Urges Device Manufacturers To Double-Check Their CAPA Systems

This article was originally published in The Silver Sheet

Executive Summary

WITH CORRECTIVE AND PREVENTIVE ACTION CITATIONS consistently showing up in FDA-483 forms and warning letters, the agency is urging medical device manufacturers to ensure that they are complying with all of the CAPA requirements in the Quality System Regulation. FDA experts offer tips on performing adequate complaint investigations, integrating risk management into the CAPA system, and performing adequate verification and validation of a corrective action... FROM WRITING GUIDANCES TO ANSWERING INDUSTRY CALLS, a workday at FDA’s device center is never routine. Compliance Officer Cap Uldriks tells how staff ensure projects get done...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT036121

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel